BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 12586027)

  • 1. [Bacteremia due to Capnocytophaga spp.: two cases].
    García J; Lizasoain M; Lahuerta JJ; Sanz F
    Enferm Infecc Microbiol Clin; 2003 Mar; 21(3):168-9. PubMed ID: 12586027
    [No Abstract]   [Full Text] [Related]  

  • 2. Trial of amifostine in autologous stem cell transplant.
    Sastry P; Bhagwat R; Biswas G; Khadwal A; Narayanan P; Bakshi A; Parikh P
    Bone Marrow Transplant; 2006 Jan; 37(1):117-8. PubMed ID: 16273114
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of the dose per body weight of conditioning chemotherapy on severity of mucositis and risk of relapse after autologous haematopoietic stem cell transplantation in relapsed diffuse large B cell lymphoma.
    Costa LJ; Micallef IN; Inwards DJ; Johnston PB; Porrata LF; Litzow MR; Ansell SM
    Br J Haematol; 2008 Oct; 143(2):268-73. PubMed ID: 18699848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose CEB vs BEAM with autologous stem cell transplant in lymphoma.
    Wang EH; Chen YA; Corringham S; Bashey A; Holman P; Ball ED; Carrier E
    Bone Marrow Transplant; 2004 Oct; 34(7):581-7. PubMed ID: 15273714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudo-bowel obstruction due to varicella zoster virus infection after autologous stem cell transplantation.
    Precupanu CM; Girodet J; Mariani P; Zanni M; Mathiot C; Escande MC; Brault P; Decaudin D
    Am J Hematol; 2009 Feb; 84(2):127-8. PubMed ID: 19127592
    [No Abstract]   [Full Text] [Related]  

  • 6. [Autologous transplant with BEAM protocol in lymphoma].
    Caballero D; Rubio V; Rifon J; Heras I; García-Sanz R; Vidriales B; Pérez-Simón JA; del Cañizo C; González M; León A; Jean-Paul E; Rocha E; Vicente V; San Miguel JF
    Sangre (Barc); 1997 Apr; 42 Suppl 1():46-9. PubMed ID: 9381303
    [No Abstract]   [Full Text] [Related]  

  • 7. [Bacteremia caused by Capnocytophaga ochracea: apropos of 2 cases].
    Viudes A; Orero A; Larrea L; Pérez Bellés C; Pérez de Léon A; Pérez Silvert M; Gobernado M
    Enferm Infecc Microbiol Clin; 1997; 15(6):338-9. PubMed ID: 9376412
    [No Abstract]   [Full Text] [Related]  

  • 8. [What is your diagnosis? Neutropenic colitis (neutropenic typhlitis)].
    Ernst S; Bühlmann M; Stucki A; Bükki J; Stanga Z
    Praxis (Bern 1994); 2007 Jan; 96(4):99-100. PubMed ID: 17294584
    [No Abstract]   [Full Text] [Related]  

  • 9. BEAM conditioning is well-tolerated and yields similar survival in obese and non-obese patients with lymphoma: no requirement for weight-based dose modifications.
    Fair C; Shanley R; Rogosheske J; Lazaryan A; McClune B; Brunstein CG; Bachanova V
    Bone Marrow Transplant; 2017 Mar; 52(3):491-493. PubMed ID: 28067889
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful autologous peripheral blood stem cell harvest and transplant in a patient with cold agglutinins.
    Crowther H; Collins D; Antonenas V; McGurgan M; Kerridge I; Gottlieb D; Bradstock K
    Bone Marrow Transplant; 2006 Feb; 37(3):329-30. PubMed ID: 16299542
    [No Abstract]   [Full Text] [Related]  

  • 11. [Capnocytophaga spp. bacteremia in compromised patients].
    Ramos JM; Pacho E; Bernacer M; Fernández-Roblas R; Soto C; Soriano F
    Enferm Infecc Microbiol Clin; 1993 Apr; 11(4):206-9. PubMed ID: 8512974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Prospective Oral Mucositis Audit: relationship of severe oral mucositis with clinical and medical resource use outcomes in patients receiving high-dose melphalan or BEAM-conditioning chemotherapy and autologous SCT.
    McCann S; Schwenkglenks M; Bacon P; Einsele H; D'Addio A; Maertens J; Niederwieser D; Rabitsch W; Roosaar A; Ruutu T; Schouten H; Stone R; Vorkurka S; Quinn B; Blijlevens N;
    Bone Marrow Transplant; 2009 Jan; 43(2):141-7. PubMed ID: 18776926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outpatient autologous hematopoietic stem cell transplantation for patients with relapsed follicular lymphoma.
    Leger C; Sabloff M; McDiarmid S; Bence-Bruckler I; Atkins H; Bredeson C; Zhang H; Huebsch L
    Ann Hematol; 2006 Oct; 85(10):723-9. PubMed ID: 16832675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe renal insufficiency is not an absolute pitfall to autologous stem cell transplantation with BeEAM (bendamustine, etoposide, cytarabine, melphalan) conditioning regimen.
    Farnault L; Venton G; Pourroy B; Jourde-Chiche N; Ivanov V; Arcani R; Roche P; Mercier C; Colle J; Fanciullino R; Costello RT
    Bone Marrow Transplant; 2019 Jul; 54(7):1173-1175. PubMed ID: 30718799
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of diverse high-dose regimens followed by autologous peripheral blood stem cell transplantation in consecutive multiple myeloma patients: a single-centre analysis over a 12-year period.
    Haas PS; Bauchmüller K; Kühnemund A; Finke J; Ihorst G; Engelhardt M
    Ann Hematol; 2006 Mar; 85(3):191-3. PubMed ID: 16365747
    [No Abstract]   [Full Text] [Related]  

  • 16. Recurrent penicillin-resistant pneumococcal sepsis after matched unrelated donor (MUD) transplantation for refractory T cell lymphoma.
    Tauro S; Dobie D; Richardson G; Hastings M; Mahendra P
    Bone Marrow Transplant; 2000 Nov; 26(9):1017-9. PubMed ID: 11100283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-escalated CHOP and tailored intensification with IFE according to early response and followed by BEAM/autologous stem-cell transplantation in poor-risk aggressive B-cell lymphoma: a prospective study from the GEL-TAMO Study Group.
    Arranz R; Conde E; Grande C; Mateos MV; Gandarillas M; Albo C; Lahuerta JJ; Fernández-Rañada JM; Hernández MT; Alonso N; García Vela JA; Garzón S; Rodríguez J; Caballero D;
    Eur J Haematol; 2008 Mar; 80(3):227-35. PubMed ID: 18088400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intensive treatment of T-cell-rich B lymphoma].
    Azaceta G; Palomera L; Varo MJ; Soria J
    Sangre (Barc); 1998 Feb; 43(1):94-5. PubMed ID: 9577190
    [No Abstract]   [Full Text] [Related]  

  • 19. Infused CD34 cell dose, but not tumour cell content of peripheral blood progenitor cell grafts, predicts clinical outcome in patients with diffuse large B-cell lymphoma and follicular lymphoma grade 3 treated with high-dose therapy.
    Blystad AK; Delabie J; Kvaløy S; Holte H; Vålerhaugen H; Ikonomou I; Kvalheim G
    Br J Haematol; 2004 Jun; 125(5):605-12. PubMed ID: 15147376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fatal bacteremia related to Capnocytophaga sputigena in a hematological patient with type T non-Hodgkin lymphoma. Diagnosis by 16S rRNA gene sequencing].
    García Lozano T; Lorente Alegre P; Linares Latorre MD; Aznar Oroval E
    Rev Argent Microbiol; 2012; 44(3):170-2. PubMed ID: 23102464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.